Beyond Air, Inc. stock is down -24.5% since 30 days ago. The next earnings date is Feb 8, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 42.86% of the previous 7 December’s closed higher than November. In the last 1 Unusual Options Trades, there were 1 CALL. 100% of analysts rate it a buy.
Beyond Air, Inc. develops nitric oxide generator and delivery systems. LungFit system is in clinical trials for the treatment of persistent pulmonary hypertension of the newborn; acute viral pneumonia, including COVID-19; bronchiolitis and nontuberculous mycobacteria lung infections; and solid tumors.